DrugPatentWatch Database Preview
Profile for Canada Patent: 2768656
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2768656
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jul 21, 2030 | Keryx Biopharms | AURYXIA | ferric citrate |
Start Trial | Jul 21, 2030 | Keryx Biopharms | AURYXIA | ferric citrate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |